Skip to main content
. 2012 May 30;303(3):F350–F356. doi: 10.1152/ajprenal.00077.2012

Table 2.

Dose-response evaluation of intrathecal KN-93 in visceral pain

KN-93 Concentration, μM Inhibition of Allodynia, % P Value
15 21.59 ± 1.9
30 59.27 ± 10.04 <0.01
45 35.45 ± 10.34 <0.05

Values are means ± SE. Inhibition is expressed as ratio of allodynia following KN-93 to allodynia preceding treatment at day 4 following pseudorabies virus.

HHS Vulnerability Disclosure